The Ebola virus: a review of progress and development in research
The Ebola virus was identified in the year 1976 and has caused periodic outbreaks in West African countries. The disease has a case fatality rate up to 90%. Ebola has been classified as a biosafety level four pathogen and there is no currently approved vaccine or treatment for the virus. However, re...
Main Authors: | Yitades Gebre, Teshome Gebre, Abena Peters |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-12-01
|
Series: | Asian Pacific Journal of Tropical Biomedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2221169115301040 |
Similar Items
-
Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus
by: Kuldeep Dhama, et al.
Published: (2018-08-01) -
Key features of Ebola hemorrhagic fever: a review
by: Zulane Lima Sousa
Published: (2014-11-01) -
Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease
by: John R. Chancellor, et al.
Published: (2016-02-01) -
Ebola virus disease: Essential clinical knowledge
by: Mahmoud Tawfik Khalafallah, et al.
Published: (2017-07-01) -
Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola
by: Jennifer K. Legardy-Williams, et al.
Published: (2020-03-01)